Jyrki Mattila Insider Trading $REPH Recro Pharma, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jyrki Mattila.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jyrki Mattila. Jyrki Mattila is Director in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Executive Vice President in AUXILIUM PHARMACEUTICALS INC ($AUXL) and Chief Business Officer in Lipocine Inc. ($LPCN) and Executive VP, Business Dev. in Recro Pharma, Inc. ($REPH).

Jyrki Mattila in Recro Pharma, Inc.

Trading Symbol: REPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jyrki Mattila: Executive VP, Business Dev.
Holdings: 11,500 shares
Current Value: $92,575
Latest Transaction: Jan 04 2018
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Jyrki Mattila in Recro Pharma, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AUXL, BSTCE, LPCN, REPH

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 04 2018	REPH	Recro Pharma, Inc.	Mattila Jyrki	Executive VP, Busin ...	Option Exercise	A	9.04	23,000	207,920	23,000
Jan 04 2018	REPH	Recro Pharma, Inc.	Mattila Jyrki	Executive VP, Busin ...	Grant	A	0.00	11,500	0	11,500	0 to 11.5 K
Aug 21 2017	REPH	Recro Pharma, Inc.	Mattila Jyrki	Executive VP, Busin ...	Option Exercise	A	0.00	12,000	0	12,000
Aug 21 2017	REPH	Recro Pharma, Inc.	Mattila Jyrki	Executive VP, Busin ...	Option Exercise	A	6.98	75,000	523,500	75,000

Page: 1